Transgenomic Quick Ratio 2010-2023 | PRPO
Transgenomic Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2023-12-31 | $0.00B | $0.00B | 1.05 |
2023-09-30 | $0.00B | $0.01B | 0.67 |
2023-06-30 | $0.00B | $0.01B | 0.81 |
2023-03-31 | $0.00B | $0.01B | 0.77 |
2022-12-31 | $0.01B | $0.00B | 1.15 |
2022-09-30 | $0.01B | $0.00B | 1.53 |
2022-06-30 | $0.01B | $0.00B | 2.04 |
2022-03-31 | $0.01B | $0.00B | 2.47 |
2021-12-31 | $0.01B | $0.00B | 3.07 |
2021-09-30 | $0.01B | $0.00B | 3.95 |
2021-06-30 | $0.02B | $0.00B | 4.52 |
2021-03-31 | $0.00B | $0.00B | 0.81 |
2020-12-31 | $0.00B | $0.01B | 0.83 |
2020-09-30 | $0.00B | $0.00B | 0.83 |
2020-06-30 | $0.00B | $0.01B | 0.38 |
2020-03-31 | $0.00B | $0.01B | 0.22 |
2019-12-31 | $0.00B | $0.00B | 0.39 |
2019-09-30 | $0.00B | $0.01B | 0.60 |
2019-06-30 | $0.00B | $0.01B | 0.45 |
2019-03-31 | $0.00B | $0.01B | 0.13 |
2018-12-31 | $0.00B | $0.01B | 0.12 |
2018-09-30 | $0.00B | $0.01B | 0.13 |
2018-06-30 | $0.00B | $0.01B | 0.11 |
2018-03-31 | $0.00B | $0.01B | 0.12 |
2017-12-31 | $0.00B | $0.01B | 0.16 |
2017-09-30 | $0.00B | $0.01B | 0.07 |
2017-06-30 | $0.00B | $0.02B | 0.10 |
2017-03-31 | $0.00B | $0.02B | 0.03 |
2016-12-31 | $0.00B | $0.00B | 0.15 |
2016-09-30 | $0.00B | $0.02B | 0.05 |
2016-06-30 | $0.00B | $0.02B | 0.10 |
2016-03-31 | $0.00B | $0.02B | 0.12 |
2015-12-31 | $0.00B | $0.02B | 0.19 |
2015-09-30 | $0.00B | $0.02B | 0.00 |
2015-06-30 | $0.01B | $0.01B | 0.97 |
2015-03-31 | $0.02B | $0.01B | 1.38 |
2014-12-31 | $0.00B | $0.01B | 0.00 |
2014-09-30 | $0.01B | $0.01B | 1.03 |
2014-06-30 | $0.01B | $0.01B | 0.96 |
2014-03-31 | $0.01B | $0.01B | 1.07 |
2013-12-31 | $0.01B | $0.01B | 0.91 |
2013-09-30 | $0.01B | $0.01B | 1.08 |
2013-06-30 | $0.02B | $0.01B | 1.96 |
2013-03-31 | $0.02B | $0.01B | 1.77 |
2012-12-31 | $0.01B | $0.02B | 0.89 |
2012-09-30 | $0.02B | $0.02B | 1.09 |
2012-06-30 | $0.03B | $0.02B | 1.68 |
2012-03-31 | $0.03B | $0.02B | 1.73 |
2011-12-31 | $0.01B | $0.02B | 0.82 |
2011-09-30 | $0.01B | $0.01B | 1.02 |
2011-06-30 | $0.01B | $0.01B | 1.08 |
2011-03-31 | $0.01B | $0.01B | 1.38 |
2010-12-31 | $0.01B | $0.01B | 1.42 |
2010-09-30 | $0.01B | $0.00B | 2.05 |
2010-06-30 | $0.01B | $0.00B | 2.29 |
2010-03-31 | $0.01B | $0.01B | 2.30 |
2009-12-31 | $0.01B | $0.00B | 2.66 |
2009-09-30 | $0.01B | $0.00B | 2.58 |
2009-06-30 | $0.01B | $0.00B | 2.38 |
2009-03-31 | $0.01B | $0.00B | 2.25 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.008B | $0.015B |
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
10x Genomics (TXG) | United States | $3.489B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
Axonics (AXNX) | United States | $3.396B | 0.00 |
Enovis (ENOV) | United States | $3.029B | 23.01 |
Azenta (AZTA) | United States | $2.925B | 238.46 |
Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
Privia Health (PRVA) | United States | $2.183B | 96.84 |
Schrodinger (SDGR) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.231B | 30.12 |
Phreesia (PHR) | United States | $1.169B | 0.00 |
Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
Standard BioTools (LAB) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
Talkspace (TALK) | United States | $0.519B | 0.00 |
Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
Pulmonx (LUNG) | United States | $0.293B | 0.00 |
P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
American Well (AMWL) | United States | $0.148B | 0.00 |
MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
Outset Medical (OM) | United States | $0.131B | 0.00 |
TruBridge (TBRG) | United States | $0.116B | 4.94 |
111 (YI) | China | $0.087B | 0.00 |
Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
Movano (MOVE) | United States | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.031B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.013B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |